Nalls Sherbakoff Group’s Labcorp LH Stock Holding History

Nalls Sherbakoff Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3	Closed	-$675	–	506
2023 Q1	$675	Buy	+3	New	+$617	﹤0.01%	468

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nalls Sherbakoff Group's LH Position: Q2 2023 in Review

Nalls Sherbakoff Group sold out of Labcorp (LH) in Q2 2023, closing a stake of 3 shares — an estimated $675 sold.

Nalls Sherbakoff Group first reported a position in LH in Q1 2023 and held it in 1 quarter. The position peaked at $675 in Q1 2023. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.

Nalls Sherbakoff Group reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
Nalls Sherbakoff Group sold 3 Labcorp shares in Q2 2023, an estimated $675.
Nalls Sherbakoff Group first reported a position in Labcorp in Q1 2023 and held it in 1 quarter.
Nalls Sherbakoff Group's Labcorp position peaked at $675 in Q1 2023.
932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2023, filed 17 Oct 2023.